Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Public ClinicalTrials.gov record NCT01270971. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults
Study identification
- NCT ID
- NCT01270971
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 594 participants
Conditions and interventions
Conditions
Interventions
- AN2690 Topical Solution, 5% Drug
- Solution Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- Nov 29, 2012
- Completion
- Jan 7, 2013
- Last update posted
- Feb 21, 2019
2010 – 2013
United States locations
- U.S. sites
- 27
- U.S. states
- 20
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Tucson | Arizona | 85741 | — |
| Investigational Site | Hot Springs | Arkansas | 71913 | — |
| Investigational Site | Burbank | California | 91505 | — |
| Investigational Site | Los Angeles | California | 90045 | — |
| Investigational Site | San Francisco | California | 94115 | — |
| Investigational Site | Denver | Colorado | 80210 | — |
| Investigational Site | Orange Park | Florida | 32073 | — |
| Investigational Site | Boise | Idaho | 83686 | — |
| Investigational Site | Evansville | Indiana | 47713 | — |
| Investigational Site | Overland Park | Kansas | 66202 | — |
| Investigational Site | Baltimore | Maryland | 21214 | — |
| Investigational Site | Fridley | Minnesota | 55432 | — |
| Investigational Site | Omaha | Nebraska | 68144 | — |
| Investigational Site | New York | New York | 10011 | — |
| Investigational Site | New York | New York | 10155 | — |
| Investigational Site | Rochester | New York | 14623 | — |
| Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| Investigational Site | Cincinnati | Ohio | 45249 | — |
| Investigational Site | South Euclid | Ohio | 44118 | — |
| Investigational Site | Portland | Oregon | 97210 | — |
| Investigational Site | Providence | Rhode Island | 02920 | — |
| Investigational Site | Germantown | Tennessee | 38138 | — |
| Investigational Site | Austin | Texas | 78759 | — |
| Investigational Site | College Station | Texas | 77845 | — |
| Investigational Site | San Antonio | Texas | 78229 | — |
| Investigational Site | Lynchburg | Virginia | 24501 | — |
| Investigational Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01270971, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2019 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01270971 live on ClinicalTrials.gov.